Relapsing multiple sclerosis – Life with Disease

Go back

Relapsing multiple sclerosis is a complex condition where the nervous system comes under repeated attack from the body’s own immune system, creating periods of worsening symptoms followed by times of recovery. Understanding what to expect as the condition unfolds over time can help patients and their families prepare for the journey ahead and make informed decisions about participation in research studies aimed at finding better treatments.

Understanding the Outlook for Relapsing Multiple Sclerosis

When someone receives a diagnosis of relapsing multiple sclerosis, one of the first questions that naturally comes to mind is what the future holds. The prognosis, or expected course of the disease, varies considerably from person to person, making it difficult to predict exactly how the condition will affect any individual over time[1].

Research indicates that without treatment, roughly one-third of people with multiple sclerosis experience significant physical disability within 20 to 25 years after their first symptoms appear[3]. This statistic, while concerning, reflects outcomes from earlier years when fewer treatment options were available. Today’s landscape looks considerably more hopeful, as various medications have been shown to slow this progression, though the long-lasting benefits of these treatments are still being studied.

The frequency of relapses can provide some insight into disease activity. Some people experience less than one relapse per year, while others may have more than two relapses annually[6]. Each relapse, even if mild or infrequent, has the potential to cause permanent damage to the central nervous system and may contribute to future disability[13]. This is why managing relapses and preventing new ones becomes such an important focus of care.

Life expectancy with multiple sclerosis has improved substantially. Recent studies show that people with MS live to an average age of 75.9 years, compared to 83.4 years for those without the condition[19]. Just a couple of decades ago, this gap was much larger. The improvement reflects better treatments and earlier diagnosis, which allows people to begin therapy when it may be most effective.

⚠️ Important
Most people diagnosed with multiple sclerosis start with the relapsing-remitting type, and approximately 85% of MS patients have this form initially[1][5]. In most cases, the pattern of the disease changes after a few decades, often becoming steadily worse rather than following the relapse-and-remission pattern[4]. This transition is something your healthcare team will monitor closely over time.

How the Disease Develops Without Treatment

Understanding the natural course of relapsing multiple sclerosis helps explain why treatment is so important. When left untreated, the disease follows a pattern that typically begins with what doctors call clinically isolated syndrome, or CIS. This is the first episode of neurological symptoms caused by inflammation and damage to the myelin—the protective covering around nerve fibers in the brain and spinal cord. Approximately 80% of patients experience this initial episode before progressing to relapsing multiple sclerosis[2].

During the relapsing-remitting phase, the immune system mistakenly attacks the myelin sheath that insulates nerve fibers. When this protective covering becomes damaged, the nerves cannot properly send signals between the brain and the rest of the body. This disruption causes the various symptoms people experience during a relapse[3][5].

As time passes, the damage accumulates. Even during periods when symptoms seem stable or have improved, silent damage may be occurring. Some relapses happen without obvious symptoms, particularly early in the disease course. These silent relapses can damage the myelin and create new lesions—areas of scarring in the brain or spinal cord—without causing noticeable disability. Medical imaging such as MRI scans can detect these hidden changes even when the person feels relatively well[6].

The body attempts to repair damaged myelin during remission periods. Sometimes this repair is complete, and symptoms disappear entirely. Other times, the repair is incomplete, leaving persistent symptoms that can be managed but may not fully resolve[1][8]. With each cycle of damage and incomplete repair, scar tissue builds up. This scarring, called sclerosis, gives the disease its name.

Over time, many people with relapsing-remitting MS transition to a phase called secondary progressive MS. In this stage, symptoms worsen more steadily rather than coming in distinct episodes. Some people may still experience occasional relapses on top of the gradual worsening[5][13]. The timeline for this transition varies widely, but it commonly occurs after several years or decades of living with the relapsing-remitting form.

Potential Complications That May Arise

Multiple sclerosis can lead to various complications beyond the primary symptoms of the disease itself. These complications sometimes develop unexpectedly and can affect multiple systems throughout the body, making comprehensive care particularly important.

People with MS face an increased vulnerability to certain health problems that can become serious if not addressed promptly. Heart disease, pneumonia, pressure ulcers, and urinary tract infections all occur more frequently in people with multiple sclerosis[19]. The risk of these complications varies depending on how severe the MS is and what type of MS someone has. For example, bladder and bowel dysfunction are common complications that can increase the risk of infections and other problems[17].

Infections deserve special attention because even mild infections, such as a sinus infection or urinary tract infection, can trigger what appears to be a relapse. These episodes are actually pseudo-exacerbations—temporary worsening of symptoms without actual new inflammation or myelin damage[1][3][8]. When the infection is treated and resolves, symptoms typically improve again. However, distinguishing between a true relapse and a pseudo-exacerbation can be challenging, especially for someone newly diagnosed.

Emotional and mental health complications are equally important to recognize. Chronic diseases like MS can cause immense emotional stress, which can lead to secondary symptoms such as fatigue, confusion, and depression[2]. Depression can also be a side effect of some MS medications, particularly corticosteroids and interferon drugs. The relationship between stress and MS symptoms creates a cycle where difficulty managing stress can complicate MS and even bring about new symptoms[16].

Other complications affect daily function and mobility. Muscle stiffness, also called spasticity, can become severe enough to interfere with movement and cause discomfort. Vision problems may develop, including temporary vision loss, double vision, or painful eye movement. Cognitive difficulties—often described as “brain fog”—can affect memory, concentration, and the ability to think clearly[1][4].

When MS affects mobility severely, additional complications may follow. Reduced movement increases the risk of blood clots, pressure sores, and muscle weakness from disuse. Falls and injuries become more likely when balance and coordination are impaired. These cascading effects highlight why early intervention and ongoing symptom management matter so much for long-term health outcomes.

Impact on Everyday Life and Activities

Living with relapsing multiple sclerosis touches nearly every aspect of daily life. The unpredictable nature of relapses means that someone might feel well one day and struggle with worsening symptoms the next. This variability makes planning ahead challenging and requires flexibility in how people approach their routines and responsibilities.

Physical activities often need adjustment. Common MS symptoms like fatigue, weakness, muscle stiffness, and balance problems can make everyday tasks more difficult. Things that once seemed simple—cooking a meal, cleaning the house, bathing, or getting dressed—may require more time, effort, or assistance[16]. For people who enjoyed active hobbies like hiking or sports, finding new ways to stay engaged with modified activities becomes important for maintaining quality of life.

Work life frequently requires changes. Many people with MS need workplace accommodations to continue performing their jobs effectively. In the United States, employers are legally required to provide reasonable accommodations for employees with disabilities. These might include allowing extra time off for medical appointments, providing assistive technology to make work tasks easier, or moving a workspace to a more accessible location[16].

Mobility changes can be among the most visible impacts. Some people benefit from using mobility aids such as braces, canes, or wheelchairs. While these devices may feel like symbols of limitation at first, many people find that they actually expand their freedom by conserving energy and improving safety. Occupational therapy can teach strategies for performing daily tasks more efficiently despite physical limitations[16].

Social relationships and family dynamics shift as well. Partners, children, and other family members often take on caregiving responsibilities. Friends may need to understand why plans sometimes need to change at the last minute due to symptom flare-ups. The emotional burden of living with uncertainty can strain relationships, making open communication particularly important.

Emotional and mental well-being require active attention. Mood problems can make MS symptoms seem worse, even when medical tests don’t show disease progression. Managing anxiety, stress, and depression through support systems, counseling, and stress-reduction activities becomes as important as managing physical symptoms[16][17].

⚠️ Important
Lifestyle choices significantly impact how MS symptoms affect daily life. Regular exercise, healthy eating, adequate sleep, stress management, and maintaining social connections all support better outcomes[17][18]. Activities that reduce stress, such as meditation and yoga, have been shown to help people manage their condition more effectively[2].

Finding new ways to enjoy beloved activities often becomes necessary. If physical limitations make previous hobbies impossible in their original form, looking for adaptations that preserve the most meaningful elements can help maintain a sense of joy and purpose. For example, someone who loved hiking for the outdoor environment and birdsong might find satisfaction in accessible nature walks or simply spending time on a patio listening to birds[16].

Building a strong support system makes navigating these changes more manageable. This might include family members, friends, healthcare providers, and other people living with MS through support groups. Nonprofit organizations also offer various forms of assistance, including grants for transportation support and caregiver services[16].

Supporting Family Members Through Clinical Trial Participation

Family members and caregivers play a crucial role throughout the entire MS journey, from initial diagnosis through ongoing treatment decisions. When it comes to clinical trials, their involvement and support can make participation possible and more manageable for the person with MS.

Understanding what clinical trials offer helps families provide meaningful support. Clinical trials test new treatments or approaches that might prove more effective than current options. For relapsing multiple sclerosis specifically, trials often focus on medications that could reduce relapse frequency, slow disease progression, or better manage symptoms. Participating in research not only gives patients potential access to promising new treatments but also contributes to advancing knowledge that may help countless others in the future.

One of the most practical ways family members can help is by assisting with the search for appropriate clinical trials. Finding relevant studies requires time and effort—searching medical databases, reading eligibility criteria, and contacting research centers for more information. Family members can take on this research task, freeing the patient to focus on managing their current health. They can compile lists of potential trials, organize information about each study’s requirements and time commitments, and help evaluate which options align best with the patient’s circumstances.

Preparing for trial participation involves many steps where family support proves invaluable. Families can help gather medical records, coordinate schedules to accommodate study visits, and arrange transportation to research sites. Many clinical trials require frequent appointments, which can be challenging to manage alone, especially when MS symptoms like fatigue or mobility problems make travel difficult. Having a family member available to drive or accompany the patient to appointments removes a significant barrier to participation.

Emotional support throughout the trial process cannot be overstated. Deciding whether to join a clinical trial can feel overwhelming. Patients may worry about side effects, wonder if they’ll receive a placebo instead of the actual treatment being tested, or feel anxious about the unknown. Family members can provide a sounding board for these concerns, help weigh the potential benefits and risks, and offer reassurance during uncertain moments. Their presence at medical appointments means there’s an extra set of ears to hear information from research staff and remember important details that might otherwise be forgotten.

During the trial itself, families often help monitor for changes in symptoms or side effects. They may notice subtle changes that the patient doesn’t recognize in themselves. This observation role becomes particularly important for trials testing treatments aimed at preventing relapses or slowing progression, where changes happen gradually over time rather than suddenly.

Families should also understand that clinical trial participation is always voluntary, and the person with MS can choose to withdraw at any time without affecting their regular medical care. Knowing this can ease pressure everyone might feel about the commitment. Family members can help ensure the patient never feels obligated to continue if the trial isn’t working out as hoped.

Learning about MS alongside the patient helps family members provide better support. Understanding what triggers symptom flare-ups—such as heat, stress, infections, lack of sleep, poor diet, smoking, or vitamin D deficiency—enables families to help create an environment that minimizes these triggers[7][17]. They can assist with meal planning to support a healthy diet, encourage regular sleep schedules, and help reduce household stressors.

For families caring for someone with MS, it’s important to recognize the demands this places on caregivers themselves. Support groups exist not just for patients but also for family members and caregivers. The National Multiple Sclerosis Society offers programs nationwide specifically designed to connect caregivers with others in similar situations[17]. Taking care of their own physical and emotional health enables family members to provide sustainable support over the long term.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of relapsing multiple sclerosis, based on the provided sources:

  • Methylprednisolone (Solu-Medrol®) – High-dose corticosteroid given by intravenous infusion to treat acute relapses by reducing inflammation in the central nervous system[8][14]
  • Dexamethasone (Decadron®) – Corticosteroid administered by IV infusion to reduce inflammation during MS relapses[8]
  • Prednisone – Oral corticosteroid sometimes prescribed after high-dose treatment to taper off steroids gradually over one to two weeks[8]
  • ACTH Gel (Acthar® Gel) – Highly purified form of adrenocorticotropin in gelatin that acts similarly to corticosteroids for treating MS relapses[8]
  • Purified Cortrophin® Gel – Highly purified ACTH in gelatin approved specifically for treatment of MS relapses[8]
  • Ocrelizumab (Ocrevus®) – B cell-depleting medication that can prevent relapses and is thought to slow disease progression, FDA-approved in 2017[6]
  • Ofatumumab (Kesimpta®) – B cell-depleting medication that can prevent relapses and is thought to slow disease progression, FDA-approved in 2020[6]

Ongoing Clinical Trials on Relapsing multiple sclerosis

  • A study to evaluate the safety and how the body uses ublituximab injections in patients with multiple sclerosis

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Poland
  • Study of ublituximab compared to fingolimod for children and teenagers aged 10 to 17 years with relapsing multiple sclerosis

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland Slovakia
  • Study comparing remibrutinib and ocrelizumab in patients with relapsing multiple sclerosis who switch from ocrelizumab treatment

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia Denmark France Germany Greece +4
  • Study on the Safety and Effects of YTB323, Tocilizumab, and Cyclophosphamide in Patients with Relapsing Multiple Sclerosis Who Have Active Disease Despite Treatment

    Recruiting

    1 1 1
    Investigated diseases:
    France Germany Italy Spain
  • Study on the Effectiveness of Ublituximab and Drug Combination for Patients with Relapsing Multiple Sclerosis

    Recruiting

    1 1 1
    Investigated diseases:
    Poland
  • Study on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis

    Recruiting

    1 1 1
    Austria Belgium Bulgaria Croatia Czechia Denmark +17
  • Study on Long-Term Safety of Tolebrutinib for Patients with Relapsing or Progressive Multiple Sclerosis

    Not yet recruiting

    1 1 1
    Denmark The Netherlands
  • Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    1 1 1
    Investigated diseases:
    Bulgaria Croatia Czechia Estonia France Germany +9
  • Study comparing subcutaneous versus intravenous ublituximab in patients with relapsing multiple sclerosis

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Croatia Czechia Hungary
  • Study on Fenebrutinib for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    Investigated diseases:
    Croatia Czechia Slovakia

References

https://my.clevelandclinic.org/health/diseases/14905-rrms-relapsing-remitting-multiple-sclerosis

https://pmc.ncbi.nlm.nih.gov/articles/PMC6753697/

https://www.copaxone.com/living-with-ms/what-is-ms

https://www.cedars-sinai.org/health-library/diseases-and-conditions/r/relapsing-remitting-multiple-sclerosis.html

https://www.plegridy.com/en_us/home/about-rms.html

https://www.yalemedicine.org/news/how-to-manage-multiple-sclerosis-ms-relapses

https://www.brighamandwomens.org/neurology/multiple-sclerosis-information/rrms

https://mymsaa.org/ms-information/treatments/relapses/

https://pmc.ncbi.nlm.nih.gov/articles/PMC8780774/

https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/diagnosis-treatment/drc-20350274

https://www.yalemedicine.org/news/how-to-manage-multiple-sclerosis-ms-relapses

https://www.va.gov/MS/TREATING_MS/Treatments_for_Multiple_Sclerosis_Relapses.asp

https://www.avonex.com/en_us/home/what-is-rms.html

https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/relapse-management-in-multiple-sclerosis-corticosteroids-remain-the-linchpin-of-therapies/32084/

https://mstrust.org.uk/information-support/ms-symptoms-diagnosis/managing-ms-relapses

https://health.clevelandclinic.org/multiple-sclerosis-self-care

https://www.hackensackmeridianhealth.org/en/healthu/2025/01/15/lifestyle-tips-to-thrive-with-multiple-sclerosis

https://www.webmd.com/multiple-sclerosis/rrms-changes-slow-progression

https://www.houstonmethodist.org/blog/articles/2025/mar/living-well-with-ms-how-to-slow-progression-reduce-symptoms-of-multiple-sclerosis/

https://www.shankleclinic.com/blog/lifestyle-tips-to-help-control-your-multiple-sclerosis

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

How long do MS relapses typically last?

Relapses typically develop quickly over a few hours or days and usually last anywhere from a few days to a few weeks, though symptoms may persist as long as two months[7][8]. At first, 12 to 18 months may pass between relapses, but as time goes on, many patients have relapses that occur more frequently and last longer[7].

What’s the difference between a true relapse and a pseudo-exacerbation?

A true relapse involves actual inflammation and damage to the myelin in your nervous system, with symptoms lasting at least 24 to 48 hours[8]. A pseudo-exacerbation is a temporary worsening of symptoms without actual myelin inflammation or damage, brought on by triggers like infection, fever, exercise, heat, stress, or exhaustion[3][8]. When the trigger is removed, symptoms from a pseudo-exacerbation typically improve.

Can stress really make my MS symptoms worse?

Yes, research shows that stress can impact the onset and severity of MS symptoms and may lead to pseudo-relapses—new or worsening symptoms that seem like disease progression but are actually your body having difficulty managing the condition under stress[16]. Managing stress through activities like meditation, yoga, adequate sleep, and maintaining social connections can have a very positive impact on overall MS management[2][16].

Should I exercise if I have MS?

Yes, exercise is actually beneficial for people with MS. Years ago doctors warned against exercise, but today they know that it strengthens muscles, eases fatigue, boosts mood, and improves quality of life[18]. An exercise program typically includes 150 minutes of aerobic activity weekly, daily stretching, and strength training twice a week[18]. Gentle activities like yoga, Pilates, swimming, or water exercises are particularly good options[17][20].

Will I always have relapsing-remitting MS, or will it change?

In most cases, the course of relapsing-remitting MS changes after a few decades. Many people transition to secondary progressive MS, where symptoms worsen more steadily rather than coming in distinct relapses[4][5]. However, with today’s disease-modifying therapies started early in the disease course, outcomes are improving, and some people maintain the relapsing-remitting pattern for longer periods[6].

🎯 Key takeaways

  • Relapsing-remitting MS is the most common form, affecting 80–85% of people diagnosed with multiple sclerosis[1][5]
  • Even mild or infrequent relapses can cause permanent damage to the central nervous system and may contribute to future disability[13]
  • Life expectancy for people with MS has improved dramatically—people with MS now live to an average of 75.9 years, compared to a much larger gap just two decades ago[19]
  • Some relapses are “silent” and damage the brain without causing noticeable symptoms, detectable only through MRI scans[6]
  • Newer treatments can prevent new brain lesions in 99% of MS patients when started early in the disease course[19]
  • Lifestyle factors including diet, exercise, sleep, stress management, and vitamin D levels significantly impact disease progression and symptom severity[17][18]
  • Heat doesn’t cause permanent MS damage—it triggers temporary symptom worsening called pseudo-exacerbation that resolves when you cool down[3][8]
  • Family support and caregivers play a vital role throughout the MS journey, and connecting with others through support groups can be life-changing for both patients and their loved ones[16][17]